Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesFinished GoodsInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

IceCure Medical (ICCM) Assets (2020 - 2025)

IceCure Medical (ICCM) has disclosed Assets for 5 consecutive years, with $12.6 million as the latest value for Q4 2024.

  • On a quarterly basis, Assets fell 23.36% to $12.6 million in Q4 2024 year-over-year; TTM through Dec 2024 was $12.6 million, a 23.36% decrease, with the full-year FY2024 number at $12.6 million, down 23.36% from a year prior.
  • Assets was $12.6 million for Q4 2024 at IceCure Medical, down from $16.4 million in the prior quarter.
  • In the past five years, Assets ranged from a high of $32.3 million in Q4 2021 to a low of $10.2 million in Q4 2020.
  • A 5-year average of $20.3 million and a median of $16.4 million in 2023 define the central range for Assets.
  • Peak YoY movement for Assets: soared 215.27% in 2021, then plummeted 45.64% in 2023.
  • IceCure Medical's Assets stood at $10.2 million in 2020, then skyrocketed by 215.27% to $32.3 million in 2021, then dropped by 6.48% to $30.2 million in 2022, then crashed by 45.64% to $16.4 million in 2023, then fell by 23.36% to $12.6 million in 2024.
  • Per Business Quant, the three most recent readings for ICCM's Assets are $12.6 million (Q4 2024), $16.4 million (Q4 2023), and $30.2 million (Q4 2022).